Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 33
18
Diseases
157
Unique genes
0.130
Avg. similarity score
Platelet-type bleeding disorder
Most-connected disease (12 links)
Disease
Searched: macrothrombocytopenia, isolated, 1, autosomal dominant
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
macrothrombocytopenia, isolated, 1, autosomal dominant
Platelet-type bleeding disorder
Macrothrombocytopenia
Platelet disorder
Thrombasthenia
Thrombocytopenia
Glanzmann thrombasthenia
Hemorrhagic disease
Carotid artery thrombosis
TPM4-related platelet disorder
platelet-type bleeding disorder 16
platelet-type bleeding disorder 15
qualitative platelet defect
bleeding disorder, platelet-type, 22
nizon-isidor syndrome
platelet-type bleeding disorder 18
Thrombocytopenia with anemia and myelofibrosis
inherited blood coagulation disorder
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Platelet-type bleeding disorder | 12 | 12 | 20 |
| Macrothrombocytopenia | 9 | 9 | 11 |
| Platelet disorder | 6 | 6 | 13 |
| Thrombasthenia | 6 | 6 | 4 |
| Thrombocytopenia | 6 | 6 | 139 |
| Glanzmann thrombasthenia | 5 | 5 | 2 |
| Hemorrhagic disease | 5 | 5 | 21 |
| Carotid artery thrombosis | 4 | 4 | 6 |
| TPM4-related platelet disorder | 4 | 4 | 1 |
| platelet-type bleeding disorder 16 | 4 | 4 | 2 |
| macrothrombocytopenia, isolated, 1, autosomal dominant | 3 | 3 | 1 |
| platelet-type bleeding disorder 15 | 3 | 3 | 1 |
| qualitative platelet defect | 3 | 3 | 2 |
| bleeding disorder, platelet-type, 22 | 2 | 2 | 1 |
| nizon-isidor syndrome | 2 | 2 | 1 |
| platelet-type bleeding disorder 18 | 2 | 2 | 1 |
| Thrombocytopenia with anemia and myelofibrosis | 1 | 1 | 1 |
| inherited blood coagulation disorder | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ITGB3 | 8 / 18 | Carotid artery thrombosis, Glanzmann thrombasthenia, Macrothrombocytopenia, Platelet disorder and 4 more |
| ITGA2B | 7 / 18 | Carotid artery thrombosis, Glanzmann thrombasthenia, Macrothrombocytopenia, Platelet-type bleeding disorder and 3 more |
| TPM4 | 6 / 18 | Hemorrhagic disease, Macrothrombocytopenia, Platelet disorder, Platelet-type bleeding disorder and 2 more |
| ACTN1 | 4 / 18 | Macrothrombocytopenia, Platelet-type bleeding disorder, platelet-type bleeding disorder 15, Thrombocytopenia |
| RASGRP2 | 4 / 18 | Platelet-type bleeding disorder, platelet-type bleeding disorder 18, Thrombasthenia, Thrombocytopenia |
| TBXA2R | 4 / 18 | Hemorrhagic disease, Platelet disorder, Platelet-type bleeding disorder, qualitative platelet defect |
| TUBB1 | 4 / 18 | Hemorrhagic disease, Macrothrombocytopenia, macrothrombocytopenia, isolated, 1, autosomal dominant, Thrombocytopenia |
| EPHB2 | 3 / 18 | bleeding disorder, platelet-type, 22, Platelet disorder, Platelet-type bleeding disorder |
| FLI1 | 3 / 18 | Platelet disorder, Platelet-type bleeding disorder, Thrombocytopenia |
| GFI1B | 3 / 18 | Macrothrombocytopenia, Platelet-type bleeding disorder, Thrombocytopenia |
| GP6 | 3 / 18 | Platelet disorder, Platelet-type bleeding disorder, Thrombocytopenia |
| ITGA2 | 3 / 18 | Platelet-type bleeding disorder, Thrombasthenia, Thrombocytopenia |
| MED12L | 3 / 18 | nizon-isidor syndrome, Platelet-type bleeding disorder, Thrombocytopenia |
| STXBP2 | 3 / 18 | Carotid artery thrombosis, Platelet disorder, Thrombocytopenia |
| ANKRD26 | 2 / 18 | Platelet disorder, Thrombocytopenia |
| APOLD1 | 2 / 18 | inherited blood coagulation disorder, Platelet-type bleeding disorder |
| ARHGEF3 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| BAK1 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| CD36 | 2 / 18 | Platelet disorder, Platelet-type bleeding disorder |
| CDKN2A | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| F7 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| GCSAML | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| GNE | 2 / 18 | Platelet-type bleeding disorder, Thrombocytopenia |
| GP1BA | 2 / 18 | Macrothrombocytopenia, Thrombocytopenia |
| GP1BB | 2 / 18 | Macrothrombocytopenia, Thrombocytopenia |
| GTF3C5 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| HBS1L | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| JAK2 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| JMJD1C | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| KLKB1 | 2 / 18 | Carotid artery thrombosis, Thrombocytopenia |
| MPIG6B | 2 / 18 | Thrombocytopenia, Thrombocytopenia with anemia and myelofibrosis |
| P2RY12 | 2 / 18 | Platelet-type bleeding disorder, Thrombocytopenia |
| PNPLA3 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| RUNX1 | 2 / 18 | Platelet disorder, Thrombocytopenia |
| SIRPA | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| SLFN14 | 2 / 18 | Platelet-type bleeding disorder, Thrombocytopenia |
| THADA | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| THBD | 2 / 18 | Carotid artery thrombosis, Thrombocytopenia |
| THPO | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| ZNF474 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
| ZNF475 | 2 / 18 | Hemorrhagic disease, Thrombocytopenia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Platelet activation | KEGG | 28 / 126 | 17.0× | 4.26e-27 | 8.46e-24 ✓ sig. |
| Platelet degranulation | Reactome | 23 / 123 | 14.3× | 1.52e-20 | 1.18e-17 ✓ sig. |
| Complement and coagulation cascades | KEGG | 17 / 88 | 14.8× | 1.09e-15 | 4.01e-13 ✓ sig. |
| p130Cas linkage to MAPK signaling for integrins | Reactome | 9 / 15 | 45.9× | 4.14e-14 | 1.12e-11 ✓ sig. |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | Reactome | 9 / 15 | 45.9× | 4.14e-14 | 1.12e-11 ✓ sig. |
| Common Pathway of Fibrin Clot Formation | Reactome | 10 / 22 | 34.8× | 6.17e-14 | 1.61e-11 ✓ sig. |
| Integrin signaling | Reactome | 10 / 23 | 33.3× | 1.08e-13 | 2.71e-11 ✓ sig. |
| Intrinsic Pathway of Fibrin Clot Formation | Reactome | 10 / 23 | 33.3× | 1.08e-13 | 2.71e-11 ✓ sig. |
| Signaling by moderate kinase activity BRAF mutants | Reactome | 12 / 47 | 19.5× | 5.74e-13 | 1.29e-10 ✓ sig. |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | Reactome | 12 / 47 | 19.5× | 5.74e-13 | 1.29e-10 ✓ sig. |
| Signaling downstream of RAS mutants | Reactome | 12 / 47 | 19.5× | 5.74e-13 | 1.29e-10 ✓ sig. |
| Signaling by high-kinase activity BRAF mutants | Reactome | 11 / 36 | 23.4× | 6.07e-13 | 1.36e-10 ✓ sig. |
| MAP2K and MAPK activation | Reactome | 11 / 40 | 21.0× | 2.23e-12 | 4.55e-10 ✓ sig. |
| Signaling by BRAF and RAF fusions | Reactome | 13 / 67 | 14.8× | 2.72e-12 | 5.45e-10 ✓ sig. |
| Hematopoietic cell lineage | KEGG | 14 / 100 | 10.7× | 3.98e-11 | 6.37e-9 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| blood coagulation | GO:0007596 | 34 / 106 | 38.2× | 2.32e-45 | 3.29e-41 ✓ sig. |
| hemostasis | GO:0007599 | 24 / 55 | 51.9× | 4.90e-36 | 3.68e-32 ✓ sig. |
| platelet aggregation | GO:0070527 | 15 / 49 | 36.4× | 4.57e-20 | 7.24e-17 ✓ sig. |
| platelet formation | GO:0030220 | 11 / 24 | 54.6× | 2.35e-17 | 2.44e-14 ✓ sig. |
| platelet activation | GO:0030168 | 14 / 69 | 24.2× | 5.03e-16 | 4.27e-13 ✓ sig. |
| megakaryocyte development | GO:0035855 | 10 / 23 | 51.8× | 1.37e-15 | 1.06e-12 ✓ sig. |
| fibrinolysis | GO:0042730 | 8 / 19 | 50.1× | 1.45e-12 | 6.51e-10 ✓ sig. |
| positive regulation of platelet activation | GO:0010572 | 7 / 13 | 64.1× | 4.25e-12 | 1.73e-9 ✓ sig. |
| plasminogen activation | GO:0031639 | 6 / 12 | 59.5× | 2.83e-10 | 7.35e-8 ✓ sig. |
| positive regulation of heterotypic cell-cell adhesion | GO:0034116 | 6 / 13 | 54.9× | 5.22e-10 | 1.27e-7 ✓ sig. |
| integrin-mediated signaling pathway | GO:0007229 | 11 / 100 | 13.1× | 7.71e-10 | 1.79e-7 ✓ sig. |
| blood coagulation, fibrin clot formation | GO:0072378 | 5 / 9 | 66.1× | 4.82e-9 | 8.93e-7 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 13 / 187 | 8.3× | 6.42e-9 | 1.16e-6 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 12 / 201 | 7.1× | 1.34e-7 | 1.59e-5 ✓ sig. |
| blood coagulation, intrinsic pathway | GO:0007597 | 4 / 8 | 59.5× | 3.27e-7 | 3.37e-5 ✓ sig. |